Using GAITRite® walkway in the evaluation of the hemiplegic adult walk treatment;Utilisation du tapis de marche GAITRite® dans l'évaluation du traitement de la marche de l'adulte hémiplégique

Science and Sports

Volumn 28, Issue 1, 2013, Pages 46-49

  Bredin, J ^a   Bruno, M ^b   Jannin, I ^a   Flambart, J P ^a  

^a Institut Rossetti PEP06   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Botulinum toxin; Gait asymmetry; Hemiplegia; Spatio temporal parameters; Variability

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; GAIT; HEMIPLEGIA; HUMAN; LEG MOVEMENT; LOCOMOTION; MEDICAL ASSESSMENT; PRIORITY JOURNAL; WALKING MACHINE; WALKING SPEED;

EID: 85027936812     PISSN: 07651597     EISSN: 17784131     Source Type: Journal    
DOI: 10.1016/j.scispo.2012.07.001     Document Type: Article

References (4)

1. D'Angéli-Chevassut M., Pélissier J., Gaviria M., Micallef J.P., Péruchon E. Caractérisation de la marche de l'hémiplégique adulte par analyse des pressions plantaires. Ann Readapt Med Phys 1996, 39(8):515-526.
2. Brisswalter J., Mottet D. Energy cost and stride duration variability at preferred transition gait speed between walking and running. Can J Appl Physiol 1996, 21:471-480.
3. Plotnik M. The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson's disease. Mov Disord 2008, 23:1639-1640.
4. Wilson D.J., Childers M.K., Cooke D.L., Smith B.K. Kinematic changes following botulinum toxin injection after traumatic brain injury. Brain Inj 1997, 11(3):157-167.